Rat hippocampal responses up to 90 days after a single nanoceria dose extends a hierarchical oxidative stress model for nanoparticle toxicity

Nanotoxicology

Volumn 8, Issue SUPPL. 1, 2014, Pages 155-166

  Hardas, Sarita S ^a   Sultana, Rukhsana ^a   Warrier, Govind ^a   Dan, Mo ^a   Wu, Peng ^b   Grulke, Eric A ^b   Tseng, Michael T ^c   Unrine, Jason M ^d   Graham, Uschi M ^a   Yokel, Robert A ^a   Butterfield, D Allan ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c University of Louisville School of Medicine   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Engineered nanomaterial; Hierarchical model; Hippocampus; Nanoceria; Oxidative stress

Indexed keywords

3 NITROTYROSINE; BIOLOGICAL MARKER; CARBONYL DERIVATIVE; CERIUM OXIDE; CERIUM OXIDE NANOPARTICLE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HEAT SHOCK PROTEIN 70; HEME OXYGENASE 1; INTERLEUKIN 1BETA; MANGANESE SUPEROXIDE DISMUTASE; NANOPARTICLE; PROCASPASE 3; PROTEIN CARBONYL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CERIC OXIDE; CERIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; AUTOPHAGY; CELL PROTECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ELECTRON ENERGY LOSS SPECTROSCOPY; ENZYME ACTIVITY; HAZARD ASSESSMENT; HIPPOCAMPUS; IN VITRO STUDY; MALE; MOLECULAR MODEL; NANOTOXICOLOGY; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CARBONYLATION; RAT; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; DRUG EFFECTS; METABOLISM; PHYSIOLOGY;

ANIMALS; CERIUM; HIPPOCAMPUS; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; OXIDATIVE STRESS; RATS;

EID: 84905992451     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.3109/17435390.2013.868059     Document Type: Article

References (116)

1. 2 nanoparticles induce DNA damage towards human dermal fibroblasts in vitro. Nanotoxicology 3: 161-71.
2. Babu S, Cho J-H, Dowding JM, Heckert E, Komanski C, Das S, et al. 2010. Multicolored redox active upconverter cerium oxide nanoparticle for bio-imaging and therapeutics. Chem Commun 46: 6915-17.
3. Barone E, Trombino S, Cassano R, Sqambato A, De Paola B, Di Stasio E, et al. 2009. Characterization of the S-denitrosylating activity of bilirubin. J Cell Mol Med 8B: 2365-75.
4. Beal MF. 2002. Oxidatively modified proteins in aging and disease. Free Radic Biol Med 32: 797-803.
5. Brown IR. 2007. Heat shock proteins and protection of the nervous system. Ann NY Acad Sci 1113: 147-58.
6. Brunner TJ, Wick P, Manser P, Spohn P, Grass RN, Limbach LK, et al. 2006. In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. Environ Sci Tech 40: 4374-81.
7. Butterfield DA, Swomley AM, Sultana R. 2013. Amyloid b-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression. Antioxid Redox Sign 19: 823-35.
8. Buzea C, Pacheco I, Robbie K. 2007. Nanomaterials and nanoparticles: sources and toxicity. Biointerphases 2: MR17-71.
9. Cai X, Sezate SA, Seal S, McGinnis JF. 2012. Sustained protection against photoreceptor degeneration in tubby mice by intravitreal injection of nanoceria. Biomaterials 33: 8771-81.
10. Calabrese V, Cornelius C, Dinkova-Kostova AT, Calabrese EJ, Mattson MP. 2010a. Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders. Antioxid Redox Sign 13: 1763-811.
11. Calabrese V, Cornelius C, Trovato A, Cavallaro M, Mancuso C, Di Rienzo L, et al. 2010b. The hormetic role of dietary antioxidants in free radical-related diseases. Curr Pharm Des 16: 877-83.
12. Calabrese V, Guagliano E, Sapienza M, Panebianco M, Calafato S, Puleo E, et al. 2007. Redox regulation of cellular stress response in aging and neurodegenerative disorders: role of vitagenes. Neurochem Res 32: 757-73.
13. Calabrese V, Scapagnini G, Ravagna A, Fariello RG, Giuffrida Stella AM, Abraham NG. 2002. Regional distribution of heme oxygenase, HSP70, and glutathione in brain: relevance for endogenous oxidant/antioxidant balance and stress tolerance. J Neurosci Res 68: 65-75.
14. Calabrese V, Stella AMG, Butterfield DA, Scapagnini G. 2004. Redox regulation in neurodegeneration and longevity: role of the heme oxygenase and HSP70 systems in brain stress tolerance. Antioxid Redox Sign 6: 895-913.
15. Cassee FR, van Balen EC, Singh C, Green D, Muijser H, Weinstein J, Dreher K. 2011. Exposure, health and ecological effects review of engineered nanoscale cerium and cerium oxide associated with its use as a fuel additive. Crit Rev Toxicol 41: 213-29.
16. Celardo I, De Nicola M, Mandoli C, Pedersen JZ, Traversa E, Ghibelli L. 2011a. Ce3+ Ions determine redox-dependent anti-apoptotic effect of cerium oxide nanoparticles. ACS Nano 5: 4537-49.
17. Celardo I, Pedersen JZ, Traversa E, Ghibelli L. 2011b. Pharmacological potential of cerium oxide nanoparticles. Nanoscale 3: 1411-20.
18. Chaudhury K, Babu KN, Singh AK, Das S, Kumar A, Seal S. 2013. Mitigation of endometriosis using regenerative cerium oxide nanoparticles. Nanomedicine 9: 439-48.
19. Chen J, Patil S, Seal S, McGinnis JF. 2006. Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides. Nat Nanotechnol 1: 142-50.
20. Chen S, Hou Y, Cheng G, Zhang C, Wang S, Zhang J. 2013. Cerium oxide nanoparticles protect endothelial cells from apoptosis induced by oxidative stress. Biol Trace Elem Res 154: 156-66.
21. Chia AJL, Goldring CE, Kitteringham NR, Wong SQ, Morgan P, Park BK. 2010. Differential effect of covalent protein modification and glutathione depletion on the transcriptional response of Nrf2 and NF-kB. Biochem Pharmacol 80: 410-21.
22. Cho WS, Duffin R, Poland CA, Howie SEM, MacNee W, Bradley M, et al. 2010. Metal oxide nanoparticles induce unique inflammatory footprints in the lung: important implications for nanoparticle testing. Environ Health Persp 118: 1699-706.
23. Ciofani G, Genchi GG, Liakos I, Cappello V, Gemmi M, Athanassiou A, et al. 2013. Effects of cerium oxide nanoparticles on PC12 neuronallike cells: proliferation, differentiation, and dopamine secretion. Pharm Res 30: 2133-45.
24. Colon J, Hsieh N, Ferguson A, Kupelian P, Seal S, Jenkins DW, Baker CH. 2010. Cerium oxide nanoparticles protect gastrointestinal epithelium from radiation-induced damage by reduction of reactive oxygen species and upregulation of superoxide dismutase 2. Nanomed Nanotechnol 6: 698-705.
25. Santucci S, Benedetti E, Di Loreto S, Phani RA, Falone S, et al. 2009. Cerium oxide nanoparticles trigger neuronal survival in a human Alzheimer disease model by modulating BDNF pathway. Curr Nanosci 5: 167-76.
26. Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. 2003. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 329: 23-38.
27. Dan M, Wu P, Grulke EA, Graham UM, Unrine JM, Yokel RA. 2012. Ceria engineered nanomaterial distribution in and clearance from blood: size matters. Nanomedicine 7: 95-110.
28. Das M, Patil S, Bhargava N, Kang JF, Riedel LM, Seal S, Hickman JJ. 2007. Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons. Biomaterials 28: 1918-25.
29. Das S, Singh S, Dowding JM, Oommenc S, Kumar A, Sayle TXT, et al. 2012. The induction of angiogenesis by cerium oxide nanoparticles through the modulation of oxygen in intracellular environments. Biomaterials 33: 7746-55.
30. Das S, Dowding JM, Klump K.E, McGinnis J.F, Self W, Seal S. 2013. Cerium oxide nanoparticles: applications and prospects in nanomedicine. Nanomedicine 8: 1483-508.
31. de Araújo SC, de Mattos AC, Teixeira HF, Coelho PM, Nelson DL, de Oliveira MC. 2007. Improvement of in vitro efficacy of a novel schistosomicidal drug by incorporation into nanoemulsions. Int J Pharm 337: 307-15.
32. Dice JF. 2007. Chaperone-mediated autophagy. Autophagy 3: 295-9.
33. Estevez AY, Pritchard S, Harper K, Aston JW, Lynch A, Lucky JJ, et al. 2011. Neuroprotective mechanisms of cerium oxide nanoparticles in a mouse hippocampal brain slice model of ischemia. Free Radic Biol Med 51: 1155-63.
34. Feng X, Sayle DC, Wang ZL, Paras MS, Santora B, Sutorik AC, et al. 2006. Converting ceria polyhedral nanoparticles into single-crystal nanospheres. Science 312: 1504-8.
35. Geraets L, Oomen AG, Schroeter JD, Coleman VA, Cassee FR. 2012. Tissue distribution of inhaled micro- and nano-sized cerium oxide particles in rats: results from a 28-day exposure study. Toxicol Sci 127: 463-73.
36. Ghosh N, Ghosh R, Mandal SC. 2011. Antioxidant protection: a promising therapeutic intervention in neurodegenerative disease. Free Radical Res 45: 888-905.
37. Glazer ES, Zhu C, Hamir AN, Borne A, Thompson CS, Curley SA. 2011. Biodistribution and acute toxicity of naked gold nanoparticles in a rabbit hepatic tumor model. Nanotoxicology 5: 459-68.
38. 2 core-shell nanoparticle-based surface-enhanced Raman probes for immunoassay of cancer marker using silica-coated magnetic nanoparticles as separation tools. 22: 1501-7.
39. Gottlieb RA, Carreira RS. 2010. Autophagy in health and disease. 5. Mitophagy as a way of life. Am J Physiol Cell Physiol 299: C203-10.
40. Graham UM, Tseng M, Jasinski J, Hardas SS, Yokel RA, Unrine J, et al. 2013. In vivo bioprocessing of nanoceria is associated with decreased oxidative stress: relevance to proposed nanoceria use and potential toxicity; submitted for publication.
41. Gupta S, Deepti A, Deegan S, Lisbona F, Hetz C, Samali A. 2010. HSP72 protects cells from ER stress-induced apoptosis via enhancement of IRE1a-XBP1 signaling through a physical interaction. PLoS Biol 8: e1000410.
42. Halliwell B, Gutteridge JMC. 2007. Free Radicals in Biology and Medicine. Oxford: Clarendon Press.
43. Hardas SS, Butterfield DA, Sultana R, Tseng MT, Dan M, Florence RL, et al. 2010. Brain distribution and toxicological evaluation of a systemically delivered engineered nanoscale ceria. Toxicol Sci 116: 562-76.
44. Hardas SS, Sultana R, Warrier G, Dan M, Florence RL, Wu P, et al. 2012. Rat brain pro-oxidant effects of peripherally administered 5 nm ceria 30 days after exposure. NeuroToxicology 33: 1147-55.
45. Hariharan N, Zhai P, Sadoshima J. 2011. Oxidative stress stimulates autophagic flux during ischemia or reperfusion. Antioxid Redox Sign 14: 2179-90.
46. Hartl FU, Hayer-Hartl M. 2002. Molecular chaperones in the cytosol: from nascent chain to folded protein. Science 295: 1852-8.
47. He X, Zhang H, Ma Y, Bai W, Zhang Z, Lu K, et al. 2010. Lung deposition and extrapulmonary translocation of nano-ceria after intratracheal instillation. Nanotechnology 21: 285103-11.
48. Heckert EG, Karakoti AS, Seal S, Self WT. 2008. The role of cerium redox state in the SOD mimetic activity of nanoceria. Biomaterials 29: 2705-9.
49. Hirst SM, Karakoti A, Singh S, Self W, Tyler R, Seal S, Reilly CM. 2013. Bio-distribution and in vivo antioxidant effects of cerium oxide nanoparticles in mice. Environ Toxicol 28: 1-12.
50. Hirst SM, Karakoti AS, Tyler RD, Sriranganathan N, Seal S, Reilly CM. 2009. Anti-inflammatory properties of cerium oxide nanoparticles. Small 5: 2848-56.
51. Hissin PJ, Hilf R. 1976. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 74: 214-26.
52. Ishigure N. 1999. Calculation of retention and excretion of some selected radionuclides after acute intake by inhalation according to new ICRP dose estimation models. J Nucl Sci Technol 36: 830-8.
53. Karakoti A, Singh S, Dowding JM, Seal S, Self WT. 2009a. Redox-active radical scavenging nanomaterials. Chem Soc Rev 39: 4422-32.
54. Karakoti AS, Singh S, Kumar A, Malinska M, Kuchibhatla SVNT, Wozniak K, et al. 2009b. PEGylated Nanoceria as radical scavenger with tunable redox chemistry. J Am Chem Soc 131: 14144-5.
55. Karakoti AS, Tsigkou O, Yue S, Lee PD, Stevens MM, Jones JR, Seal S. 2010. Rare earth oxides as nanoadditives in 3-D nanocomposite scaffolds for bone regeneration. J Mater Chem 20: 8912-19.
56. Kaushik S, Cuervo AM. 2006. Autophagy as a cell-repair mechanism: activation of chaperone-mediated autophagy during oxidative stress. Mol Aspects Med 27: 444-54.
57. Kiffin R, Christian C, Knecht E, Cuervo AM. 2004. Activation of chaperone-mediated autophagy during oxidative stress. Mol Biol Cell 15: 4829-40.
58. Korsvik C, Patil S, Seal S, Self WT. 2007. Superoxide dismutase mimetic properties exhibited by vacancy engineered ceria nanoparticles. Chem Commun 1056-8.
59. Lee H-R, Cho J-M, Shin D-h, Yong C, Choi H-G, Wakabayashi N, Kwak M-K. 2008. Adaptive response to GSH depletion and resistance to L-buthionine-(S, R)-sulfoximine: involvement of Nrf2 activation. Mol Cell Biochem 318: 23-31.
60. Li N, Alam J, Venkatesan MI, Eiguren-Fernandez A, Schmitz D, Di Stefano E, et al. 2004. Nrf2 is a key transcription factor that regulates antioxidant defense in macrophages and epithelial cells: protecting against the proinflammatory and oxidizing effects of diesel exhaust chemicals. J Immunol 173: 3467-81.
61. Lin W, Huang Y-w, Zhou X-D, Ma Y. 2006. Toxicity of cerium oxide nanoparticles in human lung cancer cells. Int J Toxicol 25: 451-7.
62. Ma JY,Zhao H, Mercer RR, Barger M, Rao M, Meighan T, Schwegler-Berry D, et al. 2011. Cerium oxide nanoparticle-induced pulmonary inflammation and alveolar macrophage functional change in rats. Nanotoxicology 5: 312-25.
63. Mancuso C, Barone E. 2009. The heme oxygenase/biliverdin reductase pathway in drug research and developement. Curr Drug Metabol 10: 579-94.
64. Mancuso C, Barone E, Guido P, Miceli F, Di Domenico F, Perluigi M, et al. 2012. Inhibition of lipid peroxidation and protein oxidation by endogeneous and exogeneous antioxidants in rat brain microsomes in vitro. Neurosci Lett 518: 101-5.
65. Mancuso C, Ragazzoni E, Tringali G, Liberale I, Preziosi P, Grossman A, Navarra P. 1999. Inhibition of heme oxygenase in the central nervous system potentiates endotoxin-induced vasopressin release in the rat. J Neuroimmunol 99: 189-94.
66. Marambio P, Toro B, Sanhueza C, Troncoso RT, Parra V, Verdejo H, et al. 2010. Glucose deprivation causes oxidative stress and stimulates aggresome formation and autophagy in cultured cardiac myocytes. Biochim Biophys Acta 18: 509-18.
67. Mattson MP. 2008. Hormesis defined. Ageing Res Rev 7: 1-7.
68. Mayer M, Bukau B. 2005. Hsp70 chaperones: cellular functions and molecular mechanism. Cell Mol Life Sci 62: 670-84.
69. Molin S, Gazda M, Jasinski P, Nowakowski A. 2008. Electrical properties of porous nanocrystalline undoped ceria oxygen sensor. Elektronika 49: 253-4.
70. Morse D, Choi AMK. 2005. Heme oxygenase-1: from bench to bedside. Am J Resp Crit Care 172: 660-70.
71. Nel A, Xia T, Madler L, Li N. 2006. Toxic potential of materials at the nanolevel. Science 311: 622-7.
72. Nesic O, Xu GY, McAdoo D, Westlund High K, Hulsebosch C, Perez-Polo R. 2004. IL-1Beta receptor antagonist prevents apoptosis and caspase-3 activation after spinal cord injury. J Neurotrauma 18: 947-56.
73. NIEHS. 2006. Chemical information profile for ceric oxide [CAS No. 1306-38-3] Supporting nomination for toxicological evaluation by the national toxicology program. Research Triangle Park, NC, USA: Integrated Laboratory Systems. National Toxicological Program, NIEHS.
74. Niu J, Azfer A, Rogers LM, Wang X, Kolattukudy PE. 2007. Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy. Cardiovasc Res 73: 549-59.
75. Niu J, Wang K, Kolattukudy PE. 2011. Cerium oxide nanoparticles inhibits oxidative stress and nuclear factor-kB activation in H9c2 cardiomyocytes exposed to cigarette smoke extract. J Pharm Exp Ther 338: 53-61.
76. Organisation for Economic Co-operation and Development (OECD). 2008. List of manufactured nanomaterials and list of endpoints for phase one of the OECD testing programme. In series on the safety of manufactured nanomaterials environment directorate. Joint meeting of the chemicals committee and the working party on chemicals, pesticides and biotechnology.
77. Organisation for Economic Co-operation and Development (OECD). 2010. Current developements/activities on the safety of manufactured nanomaterials. OECD Environment, health and safety publications series on the safety of manufactured nanomaterials. Available from: http://search.oecd.org/ officialdocuments/displaydocumentpdf/?doclanguage1/4encote1/4ENV/JM/MONO(2010)4 [last accessed 9 Dec 2013].
78. Pairon JC, Roos F, Sebastien P, Chamak B, Abd-Alsamad I, Bernaudin JF, et al. 1995. Biopersistence of cerium in the human respiratory tract and ultrastructural findings. Am J Ind Med 27: 349-58.
79. Park B, Martin P, Harris C, Guest R, Whittingham A, Jenkinson P, Handley J. 2007. Initial in vitro screening approach to investigate the potential health and environmental hazards of EnviroxTM-A nanoparticulate cerium oxide diesel fuel additive. Part Fibre Toxicol 4: 12.
80. Park EJ, Choi J, Park YK, Park K. 2008. Oxidative stress induced by cerium oxide nanoparticles in cultured BEAS-2B cells. Toxicology 245: 90-100.
81. Park EJ, Park YK, Park K. 2009. Acute toxicity and tissue distribution of cerium oxide nanoparticles by a single oral administration in rats. Toxicol Res 25: 79-84.
82. Pirmohamed T, Dowding JM, Singh S, Wasserman B, Heckert E, Karakoti AS, et al. 2010. Nanoceria exhibit redox state-dependent catalase mimetic activity. Chem Commun 46: 2736-8.
83. Poon HF, Calabrese V, Scapagnini G, Butterfield DA. 2004. Free radicals: key to brain aging and heme oxygenase as a cellular response to oxidative stress. J Gerontol A Biol Sci Med Sci 59: 478-93.
84. Pouliquen D, Le JJJ, Perdrisot R, Ermias A, Jallet P. 1991. Iron oxide nanoparticles for use as an MRI contrast agent: pharmacokinetics and metabolism. Magn Reson Imaging 9: 275-83.
85. Riviere JE. 2009. Pharmacokinetics of nanomaterials: an overview of carbon nanotubes, fullerenes and quantum dots. Wiley Interdiscip Rev Nanomed Nanobiotechnol 1: 26-34.
86. 2 nanoparticles using two aquatic microorganisms. Toxicol Sci 119: 135-45.
87. 2 nanoparticles on the soil nematode Caenorhabditis elegans using gene expression, growth, fertility, and survival as endpoints. Environ Toxicol Pharm 29: 167-72.
88. Rubinsztein David C, Mariño G, Kroemer G. 2011. Autophagy and aging. Cell 146: 682-95.
89. Ryhänen T, Hyttinen JMT, Kopitz J, Rilla K, Kuusisto E, Mannermaa E, et al. 2009. Crosstalk between Hsp70 molecular chaperone, lysosomes and proteasomes in autophagy-mediated proteolysis in human retinal pigment epithelial cells. J Cell Mol Med 13: 3616-31.
90. Sahu T, Singh Bisht S, Ranjan Das K, Kerkar S. 2013. Nanoceria: synthesis and biomedical applications. Curr NanoSci 9: 588-93.
91. Shakibaei M, John T, Seifarth C, Mobasheri ALI. 2007. Resveratrol inhibits IL-1b-induced stimulation of caspase-3 and cleavage of PARP in human articular chondrocytes in vitro. Ann NY Acad Sci 1095: 554-63.
92. Speciale A, Anwar S, Ricciardi E, Chirafisi J, Saija A, Cimino F. 2011. Cellular adaptive response to glutathione depletion modulates endothelial dysfunction triggered by TNF - A. Toxicol Lett 207: 291-7.
93. Srinivas A, Rao PJ, Selvam G, Murthy PB, Reddy PN. 2011. Acute inhalation toxicity of cerium oxide nanoparticles in rats. Toxicol Lett 205: 105-15.
94. Steiner S, Mueller L, Popovicheva OB, Raemy DO, Czerwinski J, Comte P, et al. 2012. Cerium dioxide nanoparticles can interfere with the associated cellular mechanistic response to diesel exhaust exposure. Toxicol Lett 214: 218-25.
95. Sultana R, Butterfield DA. 2009. Proteomics identification of carbonylated and HNE-bound brain proteins in Alzheimer's disease. Methods Mol Bio 566: 123-35.
96. Sultana R, Perluigi M, Butterfield DA. 2006. Protein oxidation and lipid proxidation in brain of subjects with Alzheimer's disease: Insights into mechanisms of neurodegeneration from redox proteomics. Antioxid Redox Sign 8: 2021-37.
97. Sultana R, Piroddi M, Galli F, Butterfield D. 2008. Protein levels and activity of some antioxidant enzymes in hippocampus of subjects with amnestic mild cognitive impairment. Neurochem Res 33: 2540-6.
98. 2 nanoparticles for Escherichia coli physicochemical insight of the cytotoxicity mechanism. Environ Sci Technol 40: 6151-6.
99. Tseng MT, Lu X, Duan X, Hardas SS, Sultana R, Wu P, et al. 2012. Alteration of hepatic structure and oxidative stress induced by intravenous nanoceria. Toxicol Appl Pharmacol 260: 173-82.
100. 2 nanoparticles in aquatic ecotoxicity tests. Environ Sci Technol 43: 4537-46.
101. Wason MS, Zhao J. 2013. Cerium oxide nanoparticles: potential applications for cancer and other diseases. Am J Transl Res 5: 126-31.
102. Wilhelmus MM, Waal RW, Verbeek M. 2007. Heat shock proteins and amateur chaperones in amyloid-beta accumulation and clearance in Alzheimer's disease. Mol Neurobiol 35: 203-16.
103. Witt SN. 2010. Hsp70 molecular chaperones and Parkinson's disease. Biopolymers 93: 218-28.
104. Wong LL, Hirst SM, Pye QN, Reilly CM, Seal S, McGinnis JF. 2013. Catalytic nanoceria are preferentially retained in the rat retina and are not cytotoxic after intravitreal injection. PLoS ONE 8: 11.
105. Xia T, Kovochich M, Liong M, Maüdler L, Gilbert B, Shi H, et al. 2008. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano 2: 2121-34.
106. Xia T, Li N, Nel AE. 2009. Potential health impact of nanoparticles. Ann Rev Publ Health 30: 137-50.
107. Xiao GG, Wang M, Li N, Loo JA, Nel AE. 2003. Use of proteomics to demonstrate a hierarchical oxidative stress response to diesel exhaust particle chemicals in a macrophage cell line. J Biol Chem 278: 50781-90.
108. Yenari MA, Giffard RG, Sapolsky RM, Steinberg GK. 1999. The neuroprotective potential of heat shock protein 70 (HSP70). Mol Med Today 5: 525-31.
109. Yokel RA, Au TC, MacPhail R, Hardas SS, Butterfield DA, Sultana R, et al. 2012. Distribution, elimination and biopersistence to 90 days of a systemically-introduced 30 nm ceria engineered nanomaterial in rats. Toxicol Sci 127: 256-68.
110. Yokel RA, Florence RL, Unrine JM, Tseng MT, Graham UM, Wu P, et al. 2009. Biodistribution and oxidative stress effects of a systemically- introduced commercial ceria engineered nanomaterial. Nanotoxicology 3: 234-48.
111. Yokel RA, MacPhail RC. 2011. Engineered nanomaterials: exposures, hazards, and risk prevention. J Occup Med Toxicol 6: 7.
112. Yokel RA, Tseng MT, Dan M, Unrine JM, Graham UM, Wu P, Grulke EA. 2013. Biodistribution and biopersistence of ceria engineered nanomaterials: size dependence. Nanomed Nanotechnol 9: 398-407.
113. Young JC, Barral JM, Ulrich Hartl F. 2003. More than folding: localized functions of cytosolic chaperones. Trends Biochem Sci 28: 541-7.
114. Yuan Q, Duan HH, Li LL, Sun LD, Zhang YW, Yan CH. 2009. Controlled synthesis and assembly of ceria-based nanomaterials. J Coloid Interface Sci 335: 151-67.
115. 2 nanoparticles toxicity for Escherichia coli and Synechocystis. Nanotoxicology 3: 284-95.
116. Zhou X, Wong LL, Karakoti AS, Seal S, McGinnis JF. 2011. Nanoceria inhibit the development and promote the regression of pathologic retinal neovascularization in the Vldlr knockout mouse. PLoS ONE 6: e16733.